相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Coronavirus infections and immune responses
Geng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis
Zhengtu Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
The outbreak of COVID-19: An overview
Yi-Chi Wu et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Diagnosing COVID-19: The Disease and Tools for Detection
Buddhisha Udugama et al.
ACS NANO (2020)
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan A Retrospective Observational Study
Yingzhen Du et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Liang Chen et al.
CARDIOVASCULAR RESEARCH (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential
Maroun Khoury et al.
CYTOTHERAPY (2020)
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
Bin Lou et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
Anu Haveri et al.
EUROSURVEILLANCE (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
Mingkai Tan et al.
IMMUNOLOGY (2020)
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
Farhad Seif et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
Use of Mass Cytometry to Profile Human T Cell Exhaustion
Frances Winkler et al.
FRONTIERS IN IMMUNOLOGY (2020)
Eosinophil responses during COVID-19 infections and coronavirus vaccination
Andrew W. Lindsley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Laboratory Diagnosis of COVID-19: Current Issues and Challenges
Yi-Wei Tang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Fan Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Clinical features and treatment of COVID-19 patients in northeast Chongqing
Suxin Wan et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19
Robin Patel et al.
MBIO (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Kawasaki-like disease: emerging complication during the COVID-19 pandemic
Russell M. Viner et al.
LANCET (2020)
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Lucio Verdoni et al.
LANCET (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020
Stephanie Bialek et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Irani Thevarajan et al.
NATURE MEDICINE (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
Panagiota Kontou et al.
DIAGNOSTICS (2020)
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends
Sandeep Kumar Vashist
DIAGNOSTICS (2020)
COVID-19: Immunology and treatment options
Susanna Felsenstein et al.
CLINICAL IMMUNOLOGY (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
Amene Saghazadeh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents
Ahmed Yaqinuddin et al.
MEDICAL HYPOTHESES (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
Chuang Guo et al.
NATURE COMMUNICATIONS (2020)
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
Rui Xiong et al.
PROTEIN & CELL (2020)
Serosurveys and convalescent plasma in COVID-19
Cristina Perez-Cameo et al.
ECLINICALMEDICINE (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
[Anonymous]
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)
Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Zikuan Leng et al.
AGING AND DISEASE (2020)
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
Abdurrahman Tufan et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Rudragouda Channappanavar et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
P. Ramachandran et al.
NATURE (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8+ T Cells During an Acute Retroviral Infection
Paul David et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne et al.
FRONTIERS IN IMMUNOLOGY (2019)
SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes
Chong-Shan Shi et al.
CELL DEATH DISCOVERY (2019)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Future Innovations in Viral Immune Surveillance: A Novel Place for Bioinformation and Artificial Intelligence in the Administration of Health Care
Francesco Chiappelli et al.
BIOINFORMATION (2018)
Dissecting Kawasaki disease: a state-of-the-art review
S. M. Dietz et al.
EUROPEAN JOURNAL OF PEDIATRICS (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells
Janne Tynell et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
Eu Suk Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection
Rahul Vijay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
High Secretion of Interferons by Human Plasmacytoid Dendritic Cells upon Recognition of Middle East Respiratory Syndrome Coronavirus
Vivian A. Scheuplein et al.
JOURNAL OF VIROLOGY (2015)
Macrophage activation syndrome in Kawasaki Disease: More common than we thought?
Wei Wang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Mechanical Ventilation-associated Lung Fibrosis in Acute Respiratory Distress Syndrome A Significant Contributor to Poor Outcome
Nuria E. Cabrera-Benitez et al.
ANESTHESIOLOGY (2014)
Cellular Inhibitor of Apoptosis Protein cIAP2 Protects against Pulmonary Tissue Necrosis during Influenza Virus Infection to Promote Host Survival
Ian Gael Rodrigue-Gervais et al.
CELL HOST & MICROBE (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia
Katrin Hoegner et al.
PLOS PATHOGENS (2013)
Severe Acute Respiratory Syndrome and Venous Thromboembolism in Multiple Organs
Yi Xiang-hua et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Recognition of a Kawasaki Disease Shock Syndrome
John T. Kanegaye et al.
PEDIATRICS (2009)
Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury
Yumiko Imai et al.
CELL (2008)
Metabolic modulation of inflammation-induced activation of coagulation
Marcel Levi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia
Elisabeth Kamphuis et al.
BLOOD (2006)
Type 1 interferons and the virus-host relationship:: A lesson in detente
A García-Sastre et al.
SCIENCE (2006)
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
LR Shiow et al.
NATURE (2006)
Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication
C Castilletti et al.
VIROLOGY (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS
CH Wang et al.
RESPIRATORY RESEARCH (2005)
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
JH Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
分享论文
